Parallax Volatility Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Parallax Volatility Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,500	Closed	-$28K	–	2909
2019 Q4	$28K	Hold	4,500	–	–	﹤0.01%	2271
2019 Q3	$38K	Sell	4,500 -3,000	-40%	-$22.3K	﹤0.01%	2103
2019 Q2	$50K	Hold	7,500	–	–	﹤0.01%	1976
2019 Q1	$62K	Sell	7,500 -22,000	-75%	-$227K	﹤0.01%	2226
2018 Q4	$472K	Sell	29,500 -1,970	-6%	-$43.3K	﹤0.01%	1519
2018 Q3	$1.04M	Sell	31,470 -5,530	-15%	-$142K	﹤0.01%	1253
2018 Q2	$837K	Sell	37,000 -640	-2%	-$15.2K	﹤0.01%	1141
2018 Q1	$1.09M	Sell	37,640 -33,520	-47%	-$981K	﹤0.01%	940
2017 Q4	$1.99M	Buy	71,160 +31,890	+81%	+$990K	﹤0.01%	919
2017 Q3	$1.43M	Buy	+39,270	New	+$1.21M	﹤0.01%	945

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Parallax Volatility Advisers's AVEO Position: Q1 2020 in Review

Parallax Volatility Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2020, closing a stake of 36 shares.

Parallax Volatility Advisers first reported a position in AVEO in Q4 2018 and held it in 2 quarters. The position peaked at $17K in Q4 2018. 35 funds tracked by Wall St. Rank hold AVEO as of Q1 2020.

Parallax Volatility Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 36 AVEO Pharmaceuticals, Inc. shares in Q1 2020.
Parallax Volatility Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
Parallax Volatility Advisers's AVEO Pharmaceuticals, Inc. position peaked at $17K in Q4 2018.
35 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2020.

Based on Parallax Volatility Advisers's 13F filing for Q1 2020, filed 15 May 2020.